SCHEMBL2662947

SCHEMBL2662947

C=CCc1c(C)cc(C)c(C(C)=O)c1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2649641 0.82 HSD11B1 (0.32) HSD11B1
SCHEMBL2380488 0.72 HSD11B1 (0.44) HSD11B1
SCHEMBL2649487 0.71 KDM4E (0.39)
SCHEMBL8418568 0.71 NPSR1 (0.35)
SCHEMBL12151165 0.68 GAA (0.34) HSD11B1
SCHEMBL2647665 0.66 GAA (0.38)
SCHEMBL8968442 0.66 PPARA (0.37)
SCHEMBL8968448 0.66 CXCR2 (0.35)
SCHEMBL15725320 0.66 HSD11B1 (0.33) HSD11B1
SCHEMBL25620910 0.66 HSD11B1 (0.40) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed